Virtus Fund Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $980K | Buy |
+210,666
| New | +$980K | 0.01% | 292 |
|
|
2017
Q1 | – | Sell |
-55,878
| Closed | -$327K | – | 563 |
|
|
2016
Q4 | $327K | Hold |
55,878
| – | – | ﹤0.01% | 381 |
|
|
2016
Q3 | $297K | Hold |
55,878
| – | – | ﹤0.01% | 385 |
|
|
2016
Q2 | $380K | Hold |
55,878
| – | – | ﹤0.01% | 368 |
|
|
2016
Q1 | $261K | Sell |
55,878
-12,070
| -18% | -$56.4K | ﹤0.01% | 389 |
|
|
2015
Q4 | $343K | Sell |
67,948
-714
| -1% | -$3.6K | ﹤0.01% | 369 |
|
|
2015
Q3 | $242K | Sell |
68,662
-102,028
| -60% | -$360K | ﹤0.01% | 366 |
|
|
2015
Q2 | $1.7M | Buy |
170,690
+40,734
| +31% | +$406K | 0.01% | 323 |
|
|
2015
Q1 | $1.65M | Sell |
129,956
-12,091
| -9% | -$154K | 0.01% | 333 |
|
|
2014
Q4 | $2.01M | Buy |
142,047
+687
| +0.5% | +$9.72K | 0.01% | 331 |
|
|
2014
Q3 | $1.94M | Sell |
141,360
-6,811
| -5% | -$93.7K | 0.01% | 340 |
|
|
2014
Q2 | $2.28M | Buy |
+148,171
| New | +$2.28M | 0.02% | 354 |
|